Banco Bilbao Vizcaya Argentaria, S.A. / BMY
Banco Bilbao Vizcaya Argentaria, S.A.’s Bristol-Myers Squibb Co Position
Does Banco Bilbao Vizcaya Argentaria, S.A. own Bristol-Myers Squibb Co (BMY)? Yes — 543.3K shares worth $33M (+0.23% of its 13F portfolio) as of Q1 2026, down from 641.5K shares the prior filed quarter.
Position Value
$33M
Q1 2026
Shares
543.3K
% of Portfolio
+0.23%
Quarters Held
26
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 543.3K | $33M | +0.23% |
| Q4 2025 | 641.5K | $35M | +0.24% |
| Q3 2025 | 656.3K | $30M | +0.23% |
| Q2 2025 | 638.1K | $30M | +0.27% |
| Q1 2025 | 622.5K | $38M | +0.38% |
| Q4 2024 | 621.7K | $35M | +0.37% |
| Q3 2024 | 634.9K | $33M | +0.33% |
| Q2 2024 | 517.1K | $21M | +0.27% |
| Q1 2024 | 618.0K | $33M | +0.45% |
| Q4 2023 | 590.6K | $30M | +0.42% |
| Q3 2023 | 445.0K | $26M | +0.35% |
| Q2 2023 | 510.4K | $33M | +0.42% |
| Q1 2023 | 523.1K | $36M | +0.45% |
| Q4 2022 | 520.6K | $37M | +0.55% |
| Q3 2022 | 483.2K | $34M | +0.55% |
| Q2 2022 | 503.0K | $39M | +0.58% |
| Q1 2022 | 463.9K | $34M | +0.46% |
| Q4 2021 | 291.4K | $18M | +0.24% |
| Q3 2021 | 169.5K | $10M | +0.16% |
| Q2 2021 | 149.5K | $10M | +0.18% |
| Q1 2021 | 141.6K | $9M | +0.18% |
| Q4 2020 | 126.7K | $8M | +0.18% |
| Q3 2020 | 92.6K | $6M | +0.16% |
| Q2 2020 | 97.7K | $6M | +0.18% |
| Q1 2020 | 116.7K | $7M | +0.23% |
| Q4 2019 | 105.8K | $7M | +0.21% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Banco Bilbao Vizcaya Argentaria, S.A.’s full portfolio or all institutional holders of BMY.